Cooper Joseph Patrick
SEC insider (Form 3/4/5 filer). CIK 0001368711. Director at Quoin Pharmaceuticals, Ltd. (QNRX). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 4, 2026. Located in ASHBURN, VA.
Companies Cooper Joseph Patrick has filed insider reports for
- Quoin Pharmaceuticals, Ltd. (QNRX): Director
Cooper Joseph Patrick
CIK: 0001368711
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
QNRX
Quoin Pharmaceuticals, Ltd.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 4, 2026QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
8.1K shares- - May 29, 2025QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
7.8K shares- - Dec 9, 2024QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
50.7K shares-
1-3 of 3 transactions